Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: Evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation

Joseph A. Sparano, S. Wadler, R. B. Diasio, R. Zhang, Z. Lu, E. L. Schwartz, A. Einzig, P. H. Wiernik

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: Evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation'. Together they form a unique fingerprint.

Medicine & Life Sciences